Priorities for developing respiratory syncytial virus vaccines in different target populations

The development of an effective vaccine against respiratory syncytial virus (RSV) has been hampered by major difficulties that occurred in the 1960s when a formalin-inactivated vaccine led to increased severity of RSV disease after acquisition of the virus in the RSV season after vaccination. Recent...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Sci Transl Med
Hauptverfasser: Drysdale, Simon B., Barr, Rachael S., Rollier, Christine S., Green, Christopher A., Pollard, Andrew J., Sande, Charles J.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2020
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7613568/
https://ncbi.nlm.nih.gov/pubmed/32188721
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scitranslmed.aax2466
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge